The audit found that Oregon doesn’t do enough to regulate the third-party companies that coordinate bulk prescription drug sales and insurance reimbursement rates.
SALEM, Ore. — Oregon relies on a complicated web of companies to distribute prescription drugs to pharmacies and Medicaid patients, and the overly complex and low-transparency system leads to inconsistent drug pricing and reimbursement rates that harm consumers and small pharmacies, according to an audit released Monday by the secretary of state’s office.
The state’s regulation of the system is lackluster, the audit found, particularly when it comes to oversight of Pharmacy Benefit Managers (PBMs), the third-party companies that serve as intermediaries between pharmacies,
→ Continue reading at KGW TV